Document is current
Any future updates will be listed below
-
Authors
Schwerdtfeger, Melanie http://orcid.org/0000-0001-8193-3328
Andersson, Anne-Marie Carola
Neukirch, Lasse
Holst, Peter Johannes
-
Funding
Funding for this research was provided by:
Axel Muusfeldts Fond
Augustinus Fonden (17-1151)
Magda Sofie og Aase Lütz's Mindelegat Fond
- License Information
-
More Information
Article History
Received: 19 December 2018
Accepted: 15 May 2019
First Online: 24 May 2019
Consent for publication
: Not applicable.
: The animal studies have been approved by the Danish national oversight committee on the experimentation on animals (ref. ID: 2016-15-0201-01131) and relies exclusively on purpose bred experimental animals.
: PJH is an inventor on a manuscript-related patent (published as WO2007062656) and a founder and shareholder of InProTher ApS, a biotech company which holds a license to use the invariant chain sequence for vaccination purposes against certain indications including HIV. ACA became an employee of InProTher between submission and acceptance of the manuscript.MS and LN declare that they have no competing interests.
